Taiwan Liposome Company, Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Taiwan Liposome Company, Ltd. generated cash of -$875,190,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,228,137,000 last year. Net change in cash is therefore $318,793,000.
Cash Flow
| 2011 | -235.08M | 1.02M | 504.10M |
|---|---|---|---|
| 2012 | -63.73M | -54.42M | 717.77M |
| 2013 | -360.21M | -86.59M | 2.97B |
| 2014 | -466.57M | -64.75M | 51.27M |
| 2015 | -530.65M | -80.52M | 36.35M |
| 2016 | -607.71M | -15.67M | 38.41M |
| 2017 | -819.13M | -29.49M | 4.48M |
| 2018 | -686.03M | -368.76M | 911.71M |
| 2019 | -777.56M | 252.19M | 744.00M |
| 2020 | -875.19M | -35.44M | 1.22B |
TLC Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.02B | 807.48M | 951.71M | 1.79B | 2.38B | 2.95B | 3.43B | 908.10M | 309.02M | 38.34M |
Operating activities | ||||||||||
Net income | -983.30M | -807.52M | -901.57M | -873.96M | -824.31M | -675.68M | -632.86M | -400.97M | -187.12M | -216.98M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 56.16M | 71.40M | 47.45M | 52.49M | 75.23M | 60.93M | 51.51M | 30.17M | 25.73M | 23.12M |
Stock-based compensation expense | 17.65M | 26.79M | 41.38M | 57.14M | 100.57M | 113.69M | 98.23M | 97.14M | 1.63M | 1.17M |
| Deferred income tax benefit | 17.65M | 26.79M | 41.38M | 57.14M | 100.57M | 113.69M | 98.23M | 97.14M | 1.63M | 1.17M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 5.83M | -5.77M | -721K | -701K | 17.61M | -19.71M | 145K | 29.10M | -29.81M | 1.25M |
Inventories | 0 | 0 | 136.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | -721K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -875.19M | -777.56M | -686.03M | -819.13M | -607.71M | -530.65M | -466.57M | -360.21M | -63.73M | -235.08M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -307.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -34.37M | -60.06M | -69.87M | -25.33M | -24.58M | -83.24M | -51.91M | -73.5M | -52.25M | -18.06M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -35.44M | 252.19M | -368.76M | -29.49M | -15.67M | -80.52M | -64.75M | -86.59M | -54.42M | 1.02M |
Financing activities | ||||||||||
Common Stock Issued | 680M | 836.4M | 551.35M | 0 | 6.1M | 10.62M | 0 | 2.97B | 727.27M | 500M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -390K | -512K | -350K | 0 | 0 | -36.89M | 0 | 0 | 0 | 0 |
Repayments of term debt | -508.55M | 0 | -456.87M | 0 | -25.76M | 0 | -18.51M | -19.46M | -17.50M | -13.46M |
Cash used in financing activities | 1.22B | 744.00M | 911.71M | 4.48M | 38.41M | 36.35M | 51.27M | 2.97B | 717.77M | 504.10M |
Net Change In Cash | 318.79M | 216.39M | -144.22M | -847.08M | -585.72M | -573.94M | -478.75M | 2.52B | 599.07M | 270.68M |
Cash at end of period | 1.34B | 1.02B | 807.48M | 951.71M | 1.79B | 2.38B | 2.95B | 3.43B | 908.10M | 309.02M |